Prot#2015-08:PARTNER 3 Trial: A Prospective, Randomized, Controlled, Multi-Center Study to Establish the Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients Requiring Aortic Valve Replacement who have Severe, Calcific,

Project: Research project

StatusActive
Effective start/end date5/17/16 → 5/17/22

Funding

  • Edwards Lifesciences LLC (Prot#2015-08)